Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,514
datasets available to search
ShareScore release 0.9.0
Dataset results
3,514 results for “cell therapy”
Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas
ClinicalTrials.gov study NCT02650999. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
ClinicalTrials.gov study NCT00783367. IPD Sharing: Not stated. Countries: 1. Publications: 24.
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
ClinicalTrials.gov study NCT03888105. IPD Sharing: YES. Countries: 14. Publications: 3.
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01318317. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT00799513. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)
ClinicalTrials.gov study NCT02573493. IPD Sharing: NO. Countries: 1. Publications: 1.
Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
ClinicalTrials.gov study NCT01236573. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy
ClinicalTrials.gov study NCT04071366. IPD Sharing: NO. Countries: 1. Publications: 2.
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
ClinicalTrials.gov study NCT01306045. IPD Sharing: YES. Countries: 1. Publications: 5.
Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT00984165. IPD Sharing: NO. Countries: 1. Publications: 3.
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03137771. IPD Sharing: NO. Countries: 4. Publications: 1.
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT02635009. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT03706690. IPD Sharing: YES. Countries: 10. Publications: 1.
Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)
ClinicalTrials.gov study NCT02038647. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy
ClinicalTrials.gov study NCT00694603. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)
ClinicalTrials.gov study NCT00587990. IPD Sharing: NO. Countries: 1. Publications: 1.
Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04665765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02253992. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
ClinicalTrials.gov study NCT01392989. IPD Sharing: NO. Countries: 1. Publications: 1.
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
ClinicalTrials.gov study NCT00567567. IPD Sharing: Not stated. Countries: 6. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.